You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The bill, which Congress overwhelmingly approved last week, also includes additional funding for the US Centers for Disease Control and Prevention.
Two former political appointees at the US Centers for Disease Control and Prevention describe the sidelining of the agency in the New York Times.
New names for the National Board for Education Sciences draw criticism, Science reports.
The New York Times had geneticists sequence SARS-CoV-2 samples from two journalists who contracted the virus while covering the White House.
A Nature survey finds a high level of support among scientists for former Vice President Joe Biden in the upcoming US election.
The New York Times reports on how the US Food and Drug Administration has attempted to gird against pressure from the White House.
The Washington Post reports that a herd immunity proposal has found a receptive audience at the White House to the dismay of most scientists.
A former Centers for Disease Control and Prevention director calls on the current director, Robert Redfield, to address the agency's pandemic response shortcomings, USA Today reports.
The Washington Post reports that the White House has approved new, stricter guidelines for seeking emergency authorization for a coronavirus vaccine.
Reuters reports that Germany is seeking to sequence 5 percent of patient samples that test positive for SARS-CoV-2.
23andMe and Medscape say primary care physicians are increasingly more comfortable with discussing direct-to-consumer genetic testing results.
The publisher of the Science family of journals will allow some authors to place peer-reviewed versions of their papers into publicly accessible repositories.
In Science this week: analysis of genome-wide association studies of chronic kidney disease, and more.